• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单细胞测序鉴定出与分化相关的标志物,用于 PitNET 的分子分类和复发预测。

Single-cell sequencing identifies differentiation-related markers for molecular classification and recurrence prediction of PitNET.

机构信息

Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai 200040, China; National Center for Neurological Disorders, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai 200040, China.

State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China; Institute for Stem Cell and Regeneration, Chinese Academy of Sciences, Beijing 100101, China; Beijing Institute for Stem Cell and Regenerative Medicine, Beijing 100101, China; University of Chinese Academy of Sciences, Beijing 100049, China.

出版信息

Cell Rep Med. 2023 Feb 21;4(2):100934. doi: 10.1016/j.xcrm.2023.100934. Epub 2023 Feb 7.

DOI:10.1016/j.xcrm.2023.100934
PMID:36754052
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9975294/
Abstract

Pituitary neuroendocrine tumor (PitNET) is one of the most common intracranial tumors with variable recurrence rate. Currently, the recurrence prediction is unsatisfying and can be improved by understanding the cellular origins and differentiation status. Here, to comprehensively reveal the origin of PitNET, we perform comparative analysis of single-cell RNA sequencing data from 3 anterior pituitary glands and 21 PitNETs. We identify distinct genes representing major subtypes of well and poorly differentiated PitNETs in each lineage. To further verify the predictive value of differentiation biomarkers, we include an independent cohort of 800 patients with an average follow-up of 7.2 years. In both PIT1 and TPIT lineages, poorly differentiated groups show significantly higher recurrence rates while well-differentiated groups show higher recurrence rates in SF1 lineage. Our findings reveal the possible origin and differentiation status of PitNET based on which new differentiation classification is proposed and verified to predict tumor recurrence.

摘要

垂体神经内分泌肿瘤(PitNET)是最常见的颅内肿瘤之一,其复发率存在差异。目前,对肿瘤复发的预测并不令人满意,通过了解肿瘤的细胞起源和分化状态可以对其进行改善。为了全面揭示 PitNET 的起源,我们对 3 个垂体前叶和 21 个 PitNET 的单细胞 RNA 测序数据进行了比较分析。我们在每个谱系中确定了代表分化良好和分化不良的 PitNET 主要亚型的独特基因。为了进一步验证分化标志物的预测价值,我们纳入了一个包含 800 例患者的独立队列,平均随访 7.2 年。在 PIT1 和 TPIT 谱系中,分化不良组的复发率明显较高,而在 SF1 谱系中,分化良好组的复发率较高。我们的研究结果揭示了 PitNET 的可能起源和分化状态,并基于此提出了新的分化分类方法,并对其预测肿瘤复发的能力进行了验证。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2df3/9975294/bbddd339d34e/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2df3/9975294/fe5fce3c9ee5/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2df3/9975294/22ed857cf003/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2df3/9975294/eaf116425384/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2df3/9975294/e629877a67eb/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2df3/9975294/f0800b01a680/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2df3/9975294/6777bf235f47/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2df3/9975294/c1015f4015ea/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2df3/9975294/bbddd339d34e/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2df3/9975294/fe5fce3c9ee5/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2df3/9975294/22ed857cf003/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2df3/9975294/eaf116425384/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2df3/9975294/e629877a67eb/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2df3/9975294/f0800b01a680/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2df3/9975294/6777bf235f47/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2df3/9975294/c1015f4015ea/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2df3/9975294/bbddd339d34e/gr7.jpg

相似文献

1
Single-cell sequencing identifies differentiation-related markers for molecular classification and recurrence prediction of PitNET.单细胞测序鉴定出与分化相关的标志物,用于 PitNET 的分子分类和复发预测。
Cell Rep Med. 2023 Feb 21;4(2):100934. doi: 10.1016/j.xcrm.2023.100934. Epub 2023 Feb 7.
2
Overview of the 2022 WHO Classification of Pituitary Tumors.《2022 年世卫组织垂体肿瘤分类概述》。
Endocr Pathol. 2022 Mar;33(1):6-26. doi: 10.1007/s12022-022-09703-7. Epub 2022 Mar 15.
3
Multilineage Pituitary Neuroendocrine Tumors (PitNETs) Expressing PIT1 and SF1.表达 PIT1 和 SF1 的多谱系垂体神经内分泌肿瘤(PitNETs)。
Endocr Pathol. 2023 Sep;34(3):273-278. doi: 10.1007/s12022-023-09777-x. Epub 2023 Jun 2.
4
[New pathological classification and clinical implications of pituitary neuroendocrine tumors of the 2022 WHO version].[2022年世界卫生组织版垂体神经内分泌肿瘤的新病理分类及临床意义]
Zhonghua Yi Xue Za Zhi. 2022 Dec 20;102(47):3723-3726. doi: 10.3760/cma.j.cn112137-20220417-00825.
5
[WHO Histological Classification of Pituitary Tumors].[世界卫生组织垂体肿瘤组织学分类]
No Shinkei Geka. 2023 Jul;51(4):642-653. doi: 10.11477/mf.1436204797.
6
Pituitary neuroendocrine tumors with PIT1/SF1 co-expression show distinct clinicopathological and molecular features.具有PIT1/SF1共表达的垂体神经内分泌肿瘤表现出独特的临床病理和分子特征。
Acta Neuropathol. 2024 Jan 16;147(1):16. doi: 10.1007/s00401-024-02686-1.
7
Unveiling the identities of null cell tumours: Epigenomics corroborate subtle histological cues in pituitary neuroendocrine tumour/adenoma classification.揭示无细胞肿瘤的身份:表观基因组学证实了细微的组织学线索在垂体神经内分泌肿瘤/腺瘤分类中的作用。
Neuropathol Appl Neurobiol. 2023 Feb;49(1):e12870. doi: 10.1111/nan.12870.
8
Annotation of pituitary neuroendocrine tumors with genome-wide expression analysis.基于全基因组表达分析的垂体神经内分泌肿瘤注释。
Acta Neuropathol Commun. 2021 Nov 10;9(1):181. doi: 10.1186/s40478-021-01284-6.
9
Risk of Recurrence in Pituitary Neuroendocrine Tumors: A Prospective Study Using a Five-Tiered Classification.垂体神经内分泌肿瘤的复发风险:采用五级分类的前瞻性研究。
J Clin Endocrinol Metab. 2017 Sep 1;102(9):3368-3374. doi: 10.1210/jc.2017-00773.
10
Synchronous Multiple Pituitary Neuroendocrine Tumors of Different Cell Lineages.同步发生的不同细胞谱系的垂体神经内分泌肿瘤。
Endocr Pathol. 2018 Dec;29(4):332-338. doi: 10.1007/s12022-018-9545-4.

引用本文的文献

1
Single-cell sequencing: accurate disease detection.单细胞测序:精准疾病检测。
Clin Transl Oncol. 2025 Aug 16. doi: 10.1007/s12094-025-04007-8.
2
PIT-1/SF-1-positive pituitary tumors in patients with acromegaly: transcriptomic perspective.肢端肥大症患者中PIT-1/SF-1阳性垂体瘤:转录组学视角
Acta Neuropathol Commun. 2025 Aug 14;13(1):174. doi: 10.1186/s40478-025-02091-z.
3
Whole genome sequencing and single-cell transcriptomics identify KMT2D inactivation as a potential new driver for pituitary tumors: a case report.

本文引用的文献

1
The astroglial and stem cell functions of adult rat folliculostellate cells.成年大鼠卵泡星形细胞的神经胶质和干细胞功能。
Glia. 2023 Feb;71(2):205-228. doi: 10.1002/glia.24267. Epub 2022 Sep 12.
2
Pituitary adenomas evade apoptosis via noxa deregulation in Cushing's disease.库欣病中,通过调节诺克斯(noxa)逃避细胞凋亡,导致垂体腺瘤的发生。
Cell Rep. 2022 Aug 23;40(8):111223. doi: 10.1016/j.celrep.2022.111223.
3
Doublet identification in single-cell sequencing data using .使用. 对单细胞测序数据进行重复鉴定
全基因组测序和单细胞转录组学鉴定KMT2D失活为垂体瘤的潜在新驱动因素:病例报告
BJC Rep. 2025 Jun 16;3(1):43. doi: 10.1038/s44276-025-00155-0.
4
Single-cell and spatial transcriptome analyses reveal tumor heterogeneity and immune remodeling involved in pituitary neuroendocrine tumor progression.单细胞和空间转录组分析揭示了垂体神经内分泌肿瘤进展过程中涉及的肿瘤异质性和免疫重塑。
Nat Commun. 2025 May 30;16(1):5007. doi: 10.1038/s41467-025-60028-5.
5
Spatial transcriptomics reveal PI3K-AKT and metabolic alterations in aggressive, treatment-resistant lactotroph pituitary neuroendocrine tumors.空间转录组学揭示侵袭性、耐药性催乳素细胞垂体神经内分泌肿瘤中的PI3K-AKT和代谢改变。
Acta Neuropathol Commun. 2025 May 19;13(1):107. doi: 10.1186/s40478-025-02025-9.
6
Old players and new insights: unraveling the role of RNA-binding proteins in brain tumors.老玩家与新见解:解析RNA结合蛋白在脑肿瘤中的作用
Theranostics. 2025 Apr 13;15(11):5238-5257. doi: 10.7150/thno.113312. eCollection 2025.
7
New insights in cellular senescence: The pituitary model.细胞衰老的新见解:垂体模型。
J Neuroendocrinol. 2025 May;37(5):e70008. doi: 10.1111/jne.70008. Epub 2025 Mar 3.
8
Cell Lineage-Specific Differences in Clinical Behavior of Non-Functioning Pituitary Adenomas.无功能垂体腺瘤临床行为的细胞谱系特异性差异
J Clin Endocrinol Metab. 2025 Jun 17;110(7):e2362-e2382. doi: 10.1210/clinem/dgaf112.
9
Human Pituitary Organoids: Transcriptional Landscape Deciphered by scRNA-Seq and Stereo-Seq, with Insights into SOX3's Role in Pituitary Development.人垂体类器官:通过单细胞RNA测序和空间转录组测序解析转录图谱,深入了解SOX3在垂体发育中的作用
Adv Sci (Weinh). 2025 Apr;12(14):e2414230. doi: 10.1002/advs.202414230. Epub 2025 Feb 14.
10
Splicing diversity enhances the molecular classification of pituitary neuroendocrine tumors.剪接多样性增强了垂体神经内分泌肿瘤的分子分类。
Nat Commun. 2025 Feb 11;16(1):1552. doi: 10.1038/s41467-025-56821-x.
F1000Res. 2021 Sep 28;10:979. doi: 10.12688/f1000research.73600.2. eCollection 2021.
4
Decoding the activated stem cell phenotype of the neonatally maturing pituitary.解析新生期发育的脑垂体中激活的干细胞表型。
Elife. 2022 Jun 14;11:e75742. doi: 10.7554/eLife.75742.
5
Exploring stem cell biology in pituitary tumors and derived organoids.探索垂体肿瘤和衍生类器官中的干细胞生物学。
Endocr Relat Cancer. 2022 Jun 17;29(7):427-450. doi: 10.1530/ERC-21-0374.
6
Single-cell RNA sequencing in silent corticotroph tumors confirms impaired POMC processing and provides new insights into their invasive behavior.单细胞 RNA 测序在无功能促肾上腺皮质细胞瘤中证实了 POMC 加工受损,并为其侵袭性行为提供了新的见解。
Eur J Endocrinol. 2022 May 12;187(1):49-64. doi: 10.1530/EJE-21-1183.
7
Clinical Biology of the Pituitary Adenoma.垂体腺瘤的临床生物学。
Endocr Rev. 2022 Nov 25;43(6):1003-1037. doi: 10.1210/endrev/bnac010.
8
Overview of the 2022 WHO Classification of Pituitary Tumors.《2022 年世卫组织垂体肿瘤分类概述》。
Endocr Pathol. 2022 Mar;33(1):6-26. doi: 10.1007/s12022-022-09703-7. Epub 2022 Mar 15.
9
Single nucleus transcriptome and chromatin accessibility of postmortem human pituitaries reveal diverse stem cell regulatory mechanisms.人尸垂体的单核转录组和染色质可及性揭示了多样化的干细胞调控机制。
Cell Rep. 2022 Mar 8;38(10):110467. doi: 10.1016/j.celrep.2022.110467.
10
Calcium-Prolactin Secretion Coupling in Rat Pituitary Lactotrophs Is Controlled by PI4-Kinase Alpha.钙-催乳素分泌偶联在大鼠垂体泌乳素细胞中受 PI4-激酶α调控。
Front Endocrinol (Lausanne). 2021 Dec 30;12:790441. doi: 10.3389/fendo.2021.790441. eCollection 2021.